Published in Stroke on June 01, 2001
Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial. Lancet (2013) 10.00
Validation of the supplemented Spetzler-Martin grading system for brain arteriovenous malformations in a multicenter cohort of 1009 surgical patients. Neurosurgery (2015) 2.05
Arteriovenous malformation in the adult mouse brain resembling the human disease. Ann Neurol (2011) 1.55
Endothelial Notch4 signaling induces hallmarks of brain arteriovenous malformations in mice. Proc Natl Acad Sci U S A (2008) 1.53
Common variants in interleukin-1-Beta gene are associated with intracranial hemorrhage and susceptibility to brain arteriovenous malformation. Cerebrovasc Dis (2008) 1.17
Silent intralesional microhemorrhage as a risk factor for brain arteriovenous malformation rupture. Stroke (2012) 1.08
Brain arteriovenous malformation multiplicity predicts the diagnosis of hereditary hemorrhagic telangiectasia: quantitative assessment. Stroke (2011) 1.07
Apolipoprotein E epsilon 2 is associated with new hemorrhage risk in brain arteriovenous malformations. Neurosurgery (2006) 1.01
Suppression of MMP-9 by doxycycline in brain arteriovenous malformations. BMC Neurol (2005) 0.98
Untreated brain arteriovenous malformation: patient-level meta-analysis of hemorrhage predictors. Neurology (2014) 0.94
Gene expression profiling of blood in brain arteriovenous malformation patients. Transl Stroke Res (2011) 0.90
Cerebral haemorrhage from a remote varix in the venous outflow of an arteriovenous malformation treated successfully by embolisation. Br J Radiol (2010) 0.89
Predicting visual semantic descriptive terms from radiological image data: preliminary results with liver lesions in CT. IEEE Trans Med Imaging (2014) 0.89
EPHB4 gene polymorphisms and risk of intracranial hemorrhage in patients with brain arteriovenous malformations. Circ Cardiovasc Genet (2009) 0.88
Clinical and morphological determinants of focal neurological deficits in patients with unruptured brain arteriovenous malformation. J Neurol Sci (2009) 0.86
Common variants on 9p21.3 are associated with brain arteriovenous malformations with accompanying arterial aneurysms. J Neurol Neurosurg Psychiatry (2014) 0.85
Association of tumor necrosis factor-alpha-238G>A and apolipoprotein E2 polymorphisms with intracranial hemorrhage after brain arteriovenous malformation treatment. Neurosurgery (2007) 0.84
Angiopoietin-like 4 (ANGPTL4) gene polymorphisms and risk of brain arteriovenous malformations. Cerebrovasc Dis (2011) 0.84
Influence of patient age on angioarchitecture of brain arteriovenous malformations. AJNR Am J Neuroradiol (2014) 0.83
Association between Venous Angioarchitectural Features of Sporadic Brain Arteriovenous Malformations and Intracranial Hemorrhage. AJNR Am J Neuroradiol (2015) 0.79
Late clinical and radiological complications of stereotactical radiosurgery of arteriovenous malformations of the brain. Neuroradiology (2012) 0.77
G Protein-Coupled Receptor 124 (GPR124) Gene Polymorphisms and Risk of Brain Arteriovenous Malformation. Transl Stroke Res (2012) 0.77
Subsequent haemorrhage in children with untreated brain arteriovenous malformation: Higher risk with unbalanced inflow and outflow angioarchitecture. Eur Radiol (2016) 0.77
Genome-wide association study of sporadic brain arteriovenous malformations. J Neurol Neurosurg Psychiatry (2016) 0.76
Hemorrhage rates from brain arteriovenous malformation in patients with hereditary hemorrhagic telangiectasia. Stroke (2015) 0.76
Angioarchitecture of brain arteriovenous malformations and the risk of bleeding: an analysis of patients in northeastern malaysia. Malays J Med Sci (2010) 0.75
Polymorphisms of VEGFA gene and susceptibility to hemorrhage risk of brain arteriovenous malformations in a Chinese population. Acta Pharmacol Sin (2011) 0.75
Multimodal angiographic assessment of cerebral arteriovenous malformations: a pilot study. J Neurointerv Surg (2014) 0.75
Arteriovenous Malformations in the Brain. Curr Treat Options Neurol (2002) 0.75
Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med (2010) 17.57
The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke (2001) 8.73
Spontaneous intracerebral hemorrhage. N Engl J Med (2001) 8.60
Recommendations for the establishment of primary stroke centers. Brain Attack Coalition. JAMA (2000) 7.25
Warfarin and aspirin in patients with heart failure and sinus rhythm. N Engl J Med (2012) 6.60
A proposed grading system for arteriovenous malformations. J Neurosurg (1986) 6.38
Transient ischemic attack--proposal for a new definition. N Engl J Med (2002) 4.94
Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study. Circulation (2002) 4.69
Spinal manipulative therapy is an independent risk factor for vertebral artery dissection. Neurology (2003) 4.32
Intravenous ancrod for treatment of acute ischemic stroke: the STAT study: a randomized controlled trial. Stroke Treatment with Ancrod Trial. JAMA (2000) 3.75
Influence of patient age and stenosis location on wingspan in-stent restenosis. AJNR Am J Neuroradiol (2007) 3.70
Morning increase in onset of ischemic stroke. Stroke (1989) 3.52
Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke. JAMA (2004) 3.51
Predictors of hemorrhage in patients with untreated brain arteriovenous malformation. Neurology (2006) 3.46
Good clinical outcome after ischemic stroke with successful revascularization is time-dependent. Neurology (2009) 3.45
Patent foramen ovale as a risk factor for cryptogenic stroke. Ann Intern Med (1992) 3.38
Assessment: transcranial Doppler ultrasonography: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology (2004) 3.34
Management of 100 consecutive direct carotid-cavernous fistulas: results of treatment with detachable balloons. Neurosurgery (1995) 3.22
The Harvard Cooperative Stroke Registry: a prospective registry. Neurology (1978) 3.19
Utilization of intravenous tissue-type plasminogen activator for ischemic stroke at academic medical centers: the influence of ethnicity. Stroke (2001) 3.17
From the archives of the AFIP. Imaging of musculoskeletal neurogenic tumors: radiologic-pathologic correlation. Radiographics (1999) 3.14
Infarcts of undetermined cause: the NINCDS Stroke Data Bank. Ann Neurol (1989) 3.13
The Stroke Data Bank: design, methods, and baseline characteristics. Stroke (1988) 3.12
The natural history of familial cavernous malformations: results of an ongoing study. J Neurosurg (1994) 3.06
Natural history of the cavernous angioma. J Neurosurg (1991) 3.02
Intravascular stent and endovascular coil placement for a ruptured fusiform aneurysm of the basilar artery. Case report and review of the literature. J Neurosurg (1997) 2.89
Endovascular treatment of posterior circulation aneurysms by electrothrombosis using electrically detachable coils. J Neurosurg (1992) 2.86
Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. Stroke (1999) 2.85
Should thrombolytic therapy be the first-line treatment for acute ischemic stroke? Thrombolysis--not a panacea for ischemic stroke. N Engl J Med (1997) 2.82
Occurrence and predictors of futile recanalization following endovascular treatment among patients with acute ischemic stroke: a multicenter study. AJNR Am J Neuroradiol (2010) 2.80
Civilian gunshot wounds to the head: a prospective study. Neurosurgery (1990) 2.77
Global experience in cervical carotid artery stent placement. Catheter Cardiovasc Interv (2000) 2.77
De novo formation of a central nervous system cavernous malformation: implications for predicting risk of hemorrhage. Case report and review of the literature. J Neurosurg (1997) 2.72
Contrast extravasation on CT predicts mortality in primary intracerebral hemorrhage. AJNR Am J Neuroradiol (2007) 2.69
Differential CC chemokine-induced enhancement of T helper cell cytokine production. J Immunol (1997) 2.68
Cerebral cavernous malformations. Incidence and familial occurrence. N Engl J Med (1988) 2.65
Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke (2001) 2.65
Early stroke risk and ABCD2 score performance in tissue- vs time-defined TIA: a multicenter study. Neurology (2011) 2.62
Carotid cavernous fistulae: indications for urgent treatment. AJR Am J Roentgenol (1987) 2.60
Endovascular therapeutic approach to peripheral aneurysms of the superior cerebellar artery. AJNR Am J Neuroradiol (1996) 2.55
Broca aphasia: pathologic and clinical. Neurology (1978) 2.43
The New York Islands AVM Study: design, study progress, and initial results. Stroke (2003) 2.42
Aortic arch plaques and risk of recurrent stroke and death. Circulation (2009) 2.40
Prior antiplatelet therapy and outcome following intracerebral hemorrhage: a systematic review. Neurology (2010) 2.39
Preoperative proton MR spectroscopic imaging of brain tumors: correlation with histopathologic analysis of resection specimens. AJNR Am J Neuroradiol (2001) 2.34
Superiority of transesophageal echocardiography in detecting cardiac source of embolism in patients with cerebral ischemia of uncertain etiology. J Am Coll Cardiol (1991) 2.34
Central poststroke pain and Wallenberg's lateral medullary infarction: frequency, character, and determinants in 63 patients. Neurology (1997) 2.28
Late angiographic follow-up review of surgically treated aneurysms. J Neurosurg (1999) 2.23
Transvenous embolization of direct carotid cavernous fistulas. AJNR Am J Neuroradiol (1988) 2.22
Neurologic deterioration in noncomatose patients with supratentorial intracerebral hemorrhage. Neurology (1994) 2.21
Intracerebral hemorrhage: external validation and extension of a model for prediction of 30-day survival. Ann Neurol (1991) 2.20
Endovascular and surgical treatment of unruptured cerebral aneurysms: comparison of risks. Ann Neurol (2000) 2.20
Intracranial aneurysms: interventional neurovascular treatment with detachable balloons--results in 215 cases. Radiology (1991) 2.18
Multilocus linkage identifies two new loci for a mendelian form of stroke, cerebral cavernous malformation, at 7p15-13 and 3q25.2-27. Hum Mol Genet (1998) 2.16
The many faces of PHACE syndrome. J Pediatr (2001) 2.16
Delayed aneurysm regrowth and recanalization after Guglielmi detachable coil treatment. Case report. J Neurosurg (1998) 2.14
The natural history of CADASIL: a pooled analysis of previously published cases. Stroke (1999) 2.14
Impact of traumatic subarachnoid hemorrhage on outcome in nonpenetrating head injury. Part II: Relationship to clinical course and outcome variables during acute hospitalization. J Trauma (1996) 2.13
The efficacy of endosaccular aneurysm occlusion in alleviating neurological deficits produced by mass effect. J Neurosurg (1994) 2.10
Clinical endpoints in peripheral endovascular revascularization trials: a case for standardized definitions. Eur J Vasc Endovasc Surg (2008) 2.10
From the archives of the AFIP. Primary tumors of the spine: radiologic pathologic correlation. Radiographics (1996) 2.07
Role of conventional angiography in evaluation of patients with carotid artery stenosis demonstrated by Doppler ultrasound in general practice. Stroke (2001) 2.05
A strangled wife. Lancet (1999) 2.04
From the archives of the AFIP. Musculoskeletal angiomatous lesions: radiologic-pathologic correlation. Radiographics (1995) 2.02
Hemangiomas and vascular malformations of the head and neck: MR characterization. AJNR Am J Neuroradiol (1993) 1.99
Normal appearance of arachnoid granulations on contrast-enhanced CT and MR of the brain: differentiation from dural sinus disease. AJNR Am J Neuroradiol (1996) 1.98
Do-not-resuscitate orders and predictive models after intracerebral hemorrhage. Neurology (2010) 1.97
Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. II. Postmortem pathological correlations. Stroke (1987) 1.96
The MRI appearance of cavernous malformations (angiomas). J Neurosurg (1987) 1.93
Prediction of intracerebral hemorrhage survival. Ann Neurol (1988) 1.92
Behavioral studies of aphasia: methods of investigation and analysis. Neuropsychologia (1971) 1.92
Efficacy and current limitations of intravascular stents for intracranial internal carotid, vertebral, and basilar artery aneurysms. J Neurosurg (1999) 1.90
Transarterial occlusion of solitary intracerebral arteriovenous fistulas. AJNR Am J Neuroradiol (1989) 1.88
Normal perfusion pressure breakthrough theory. Clin Neurosurg (1978) 1.87
Patterns and mechanisms of lumbar injuries associated with lap seat belts. J Bone Joint Surg Am (1969) 1.83
Transluminal angioplasty for atherosclerotic disease of the vertebral and basilar arteries. J Neurosurg (1993) 1.81
Urgent endovascular revascularization for symptomatic intracranial atherosclerotic stenosis. Neurology (2003) 1.81
The persistent fetal carotid-vertebrobasilar anastomoses. AJR Am J Roentgenol (1999) 1.80
Management of tentorial dural arteriovenous malformations: transarterial embolization combined with stereotactic radiation or surgery. J Neurosurg (1994) 1.80
Clomethiazole Acute Stroke Study in ischemic stroke (CLASS-I): final results. Stroke (2002) 1.80